Research Study

Canadian-Australasian Randomized Trial of Screening Kidney Transplant Candidates for Coronary Artery Disease (CARSK)
Principal Investigator 
Jagbir Gill

Overview

Body Locations and Systems 
Diagnosis and Therapy 
Kidney Transplantation
Status 
Recruiting
Study Start/End 
Aug 15, 2016 to Dec 31, 2024
Locations 
St. Paul's Hospital, Vancouver General Hospital
Name/Title 
Angela Ogniben, Research Coordinator
Phone 
604-682-2344 ext.64707
Purpose of Study 

Patients on the waiting list for kidney transplantation are at risk for coronary artery disease (CAD).  The optimal strategy to monitor and maintain the cardiac fitness of these patients is unknown. Currently patients without any symptoms of CAD undergo annual testing to determine if they have disease. This study will determine if screening is necessary. The results will either make better use of scarce deceased donor kidneys by informing better management of waitlist patients, or save valuable resources due to averting needless and potentially harmful tests in patients without symptoms. 

Eligibility 
  • Adults aged 18 years or older
  • Dialysis-dependent and currently being assessed for or active on the kidney transplant waiting list
  • Expected to require further screening for CAD prior to transplantation (by current standard of care)
  • Able to give consent
  • Anticipated to undergo transplantation more than 12 months from date of enrolment 
Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.